NPs Basic Information
|
Name |
2,3,5-Trimethylhexane
|
| Molecular Formula | C9H20 | |
| IUPAC Name* |
2,3,5-trimethylhexane
|
|
| SMILES |
CC(C)CC(C)C(C)C
|
|
| InChI |
InChI=1S/C9H20/c1-7(2)6-9(5)8(3)4/h7-9H,6H2,1-5H3
|
|
| InChIKey |
ODGLTLJZCVNPBU-UHFFFAOYSA-N
|
|
| Synonyms |
2,3,5-TRIMETHYLHEXANE; 1069-53-0; Hexane, 2,3,5-trimethyl-; Hexane,2,3,5-trimethyl-; EINECS 213-957-6; 2,3,5-trimethyl-hexane; DTXSID70870833; CHEBI:141559; AKOS006271489; FT-0732512; Q5651194
|
|
| CAS | 1069-53-0 | |
| PubChem CID | 14045 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 128.25 | ALogp: | 4.2 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
| Heavy Atoms: | 9 | QED Weighted: | 0.537 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.233 | MDCK Permeability: | 0.00002010 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.589 |
| 30% Bioavailability (F30%): | 0.866 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.818 | Plasma Protein Binding (PPB): | 94.35% |
| Volume Distribution (VD): | 1.908 | Fu: | 4.92% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.735 | CYP1A2-substrate: | 0.597 |
| CYP2C19-inhibitor: | 0.173 | CYP2C19-substrate: | 0.937 |
| CYP2C9-inhibitor: | 0.67 | CYP2C9-substrate: | 0.456 |
| CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.081 |
| CYP3A4-inhibitor: | 0.087 | CYP3A4-substrate: | 0.389 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 12.266 | Half-life (T1/2): | 0.282 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.027 |
| Drug-inuced Liver Injury (DILI): | 0.246 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.038 | Maximum Recommended Daily Dose: | 0.035 |
| Skin Sensitization: | 0.088 | Carcinogencity: | 0.064 |
| Eye Corrosion: | 0.978 | Eye Irritation: | 0.992 |
| Respiratory Toxicity: | 0.054 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000462 |  |
0.517 | D0B2OT |  |
0.256 | ||
| ENC001213 |  |
0.486 | D00WUF |  |
0.250 | ||
| ENC001158 |  |
0.474 | D0A3HB |  |
0.217 | ||
| ENC002241 |  |
0.471 | D08KVZ |  |
0.197 | ||
| ENC000505 |  |
0.406 | D04MWJ |  |
0.195 | ||
| ENC005689 |  |
0.406 | D0R1QE |  |
0.192 | ||
| ENC001207 |  |
0.400 | D0P7VJ |  |
0.177 | ||
| ENC000619 |  |
0.400 | D02EZM |  |
0.175 | ||
| ENC001171 |  |
0.368 | D0BZ7W |  |
0.173 | ||
| ENC000187 |  |
0.343 | D0YQ5L |  |
0.173 | ||